JAIDS Journal of Acquired Immune Deficiency Syndromes · 2004 · 50 citations · 8 references
Public HealthInfectious DiseasesPharmacokineticsReproductive MedicineVirologyWomen's HealthAntiretroviral TherapyAntiviral AgentsPre-exposure ProphylaxisPrevention Of Sexual TransmissionSexually Transmitted Infection PreventionSexually Transmitted InfectionsDrug Efficacy TestingHiv Prevention In WomenNucleoside Reverse Transcriptase InhibitorsPharmacokinetics Of Antiretroviral DrugsResistance To Viral InfectionSexual Transmission DynamicsVaginal Pharmacokinetics
The pharmacokinetics of antiretrovirals (ARVs) in the female genital tract (FGT) are likely to influence vertical and sexual transmission of HIV, the development of viral resistance, and post-exposure prophylaxis regimens. This study is the first to compare ARV concentrations in direct aspirates of cervicovaginal fluid (CVF) and blood plasma (BP). This unique method provides direct assessment of concentrations without the confounding of cervicovaginal lavage dilution. Of 8 ARVs, CVF concentrations ranged from <10% to >100% of BP concentrations. These large differences in CVF penetration suggest that further research into ARV pharmacokinetics and drug efficacy in the FGT is necessary.
8
Transmission of antiretroviral-drug-resistant HIV-1 variants
Sabine Yerly, Laurent Kaiser, Esther Race et al. · The Lancet · 1999 · 397 citations
Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract
Patricia Reichelderfer, Robert W. Coombs, David J. Wright et al. · AIDS · 2000 · 111 citations
Ali Si‐Mohamed, Michel D. Kazatchkine, Isabelle Heard et al. · The Journal of Infectious Diseases · 2000 · 96 citations · Full text
Lori Panther, Lynne Tucker, Chuanqing Xu et al. · The Journal of Infectious Diseases · 2000 · 50 citations